Lupin

Lupin Launches Bosentan Tablets for Oral Suspension in the United States
with 180-Day Exclusivity

Lupin Launches Bosentan Tablets for Oral Suspension in the United States with 180-Day Exclusivity

20 Aug 2025

1 min read

Lupin, Sandoz Partner to Expand Global Reach of Ranibizumab Biosimilar

Lupin, Sandoz Partner to Expand Global Reach of Ranibizumab Biosimilar

13 Aug 2025

1 min read

Lupin Partners with Sandoz for Global Launch of Biosimilar Ranibizumab

Lupin Partners with Sandoz for Global Launch of Biosimilar Ranibizumab

12 Aug 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com